Gastrointestinal stromal tumours that harbour different KIT or PDGFRA mutations have different molecular signatures at the level of gene expression, which further contributes to the complexity of GIST biology and variable response to treatment (Antonescu et al, 2004). This evidence concerns the gene KIT and gastrointestinal stromal tumor.